In Licensing

We constantly seek to strengthen our product portfolio and market presence by building successful partnerships. Our major focus markets primarily comprise of GCC and Middle East. In parallel, we are also constantly evaluating opportunities for US, Europe and ROW markets.

Therapeutic categories of primary interest for In-licensing products include-

• Infectious Disease
• Pain Management
• Women’s Health
• Metabolic Diseases
• Urology

We will consider other opportunities as well beyond these therapeutic areas.

OPP has implemented a streamlined in-licensing process in order to provide a rapid evaluation of potential opportunities.

For In-Licensing enquiries please contact us at bd@omanpharma.com